X
RLAY icon

Xponance’s Relay Therapeutics RLAY Stock Holding History

Xponance’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Buy
15,963
+3,111
+24% +$45.2K ﹤0.01% 1407
2026
Q1 		$128K Buy
12,852
+1,850
+17% +$16.6K ﹤0.01% 1539
2025
Q4 		$93.1K Buy
11,002
+666
+6% +$4.75K ﹤0.01% 1477
2025
Q3 		$54K Buy
10,336
+63
+0.6% +$240 ﹤0.01% 1483
2025
Q2 		$35.5K Buy
+10,273
New +$30.6K ﹤0.01% 1475

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Xponance's RLAY Position: Q2 2026 in Review

Xponance increased its Relay Therapeutics (RLAY) stake by 24% in Q2 2026, buying an estimated $45.2K and bringing the position to 15,963 shares worth $299K. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Xponance first reported a position in RLAY in Q2 2025 and has held it in 5 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Xponance held 15,963 shares of Relay Therapeutics worth $299K as of Q2 2026.
  • Xponance bought 3,111 Relay Therapeutics shares in Q2 2026, an estimated $45.2K.
  • Relay Therapeutics made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1407 holding.
  • Xponance first reported a position in Relay Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.